T39M (p.Thr39Met) variant of GLA (Alpha-galactosidase A)

T39M (p.Thr39Met) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar and UniProt describe it as uncertain significance in the context of Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.74 / 1. The record also includes population frequency data and structural context.

T39M (p.Thr39Met) variant details